Found: 8
Select item for more details and to access through your institution.
T9 cells in anti-tumor immunity.
- Published in:
- Seminars in Immunopathology, 2017, v. 39, n. 1, p. 39, doi. 10.1007/s00281-016-0599-4
- By:
- Publication type:
- Article
PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Corrigendum: The receptor NLRP3 is a transcriptional regulator of T<sub>H</sub>2 differentiation.
- Published in:
- Nature Immunology, 2015, v. 16, n. 12, p. 1292, doi. 10.1038/ni1215-1292a
- By:
- Publication type:
- Article
The receptor NLRP3 is a transcriptional regulator of T<sub>H</sub>2 differentiation.
- Published in:
- Nature Immunology, 2015, v. 16, n. 8, p. 859, doi. 10.1038/ni.3202
- By:
- Publication type:
- Article
Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1<sup>+</sup> PD-1<sup>+</sup> CD8 T cells.
- Published in:
- Science Immunology, 2023, v. 8, n. 86, p. 1, doi. 10.1126/sciimmunol.adg0878
- By:
- Publication type:
- Article
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02732-5
- By:
- Publication type:
- Article
IRF8-dependent molecular complexes control the Th9 transcriptional program.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01070-w
- By:
- Publication type:
- Article
Advancing beyond the twists and turns of T cell exhaustion in cancer.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abo4997
- By:
- Publication type:
- Article